Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.

Raghunathan PL, Jones JD, Tiendrebéogo SR, Sanou I, Sangaré L, Kouanda S, Dabal M, Lingani C, Elie CM, Johnson S, Ari M, Martinez J, Chatt J, Sidibe K, Schmink S, Mayer LW, Kondé MK, Djingarey MH, Popovic T, Plikaytis BD, Carlone GM, Rosenstein N, Soriano-Gabarró M.

J Infect Dis. 2006 Mar 1;193(5):607-16. Epub 2006 Jan 30.

PMID:
16453255
2.

No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

Baggett HC, Rhodes JC, Fridkin SK, Quinn CP, Hageman JC, Friedman CR, Dykewicz CA, Semenova VA, Romero-Steiner S, Elie CM, Jernigan JA.

Clin Infect Dis. 2005 Oct 1;41(7):991-7. Epub 2005 Aug 29.

PMID:
16142664
3.

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.

Quinn CP, Dull PM, Semenova V, Li H, Crotty S, Taylor TH, Steward-Clark E, Stamey KL, Schmidt DS, Stinson KW, Freeman AE, Elie CM, Martin SK, Greene C, Aubert RD, Glidewell J, Perkins BA, Ahmed R, Stephens DS.

J Infect Dis. 2004 Oct 1;190(7):1228-36. Epub 2004 Aug 30.

PMID:
15346332
4.

Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults.

Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, Breiman RF.

Clin Diagn Lab Immunol. 2004 Jan;11(1):137-41.

5.
6.
7.

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, Stamey K, Steward-Clark E, Schmidt DS, Mothershed E, Pruckler J, Schwartz S, Benson RF, Helsel LO, Holder PF, Johnson SE, Kellum M, Messmer T, Thacker WL, Besser L, Plikaytis BD, Taylor TH Jr, Freeman AE, Wallace KJ, Dull P, Sejvar J, Bruce E, Moreno R, Schuchat A, Lingappa JR, Martin SK, Walls J, Bronsdon M, Carlone GM, Bajani-Ari M, Ashford DA, Stephens DS, Perkins BA.

Emerg Infect Dis. 2002 Oct;8(10):1103-10.

8.

Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.

Goetz MB, Feikin DR, Lennox JL, O'Brien WA, Elie CM, Butler JC, Breiman RF.

AIDS. 2002 Jul 5;16(10):1421-3.

PMID:
12131220
9.
10.

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults.

Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, Holder PF, O'Brien WA, Whitney CG, Butler JC, Breiman RF.

Vaccine. 2001 Nov 12;20(3-4):545-53.

PMID:
11672921
11.

Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.

Lasker BA, Elie CM, Lott TJ, Espinel-Ingroff A, Gallagher L, Kuykendall RJ, Kellum ME, Pruitt WR, Warnock DW, Rimland D, McNeil MM, Reiss E.

Med Mycol. 2001 Aug;39(4):341-52.

PMID:
11556764
12.
13.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Plikaytis BD, Goldblatt D, Frasch CE, Blondeau C, Bybel MJ, Giebink GS, Jonsdottir I, Käyhty H, Konradsen HB, Madore DV, Nahm MH, Schulman CA, Holder PF, Lezhava T, Elie CM, Carlone GM.

J Clin Microbiol. 2000 Jun;38(6):2043-50.

14.

Rapid identification of Candida species with species-specific DNA probes.

Elie CM, Lott TJ, Reiss E, Morrison CJ.

J Clin Microbiol. 1998 Nov;36(11):3260-5.

15.

Sequence analysis of the internal transcribed spacer 2 (ITS2) from yeast species within the genus Candida.

Lott TJ, Burns BM, Zancope-Oliveira R, Elie CM, Reiss E.

Curr Microbiol. 1998 Feb;36(2):63-9.

PMID:
9425241

Supplemental Content

Support Center